WAVERLEY PHARMA MANAGEMENT
Theron Odlaug, PhD
CEO, Waverley Pharma Inc.
Dr. Theron (Ted) Odlaug brings over 35 years of experience with significant leadership roles in the pharmaceutical industry. Ted was appointed CEO of Waverley Pharma in August 2018.
Ted is a Board Member at CoreRx Inc., leon-nanodrugs GmbH, Carstens Inc, and a Venture Partner with Signet Healthcare Advisors. He is also a fundraiser for the Dravet Syndrome Foundation. He was recently the Executive Chairman of Impopharma Inc, and before that the CEO of leon-nanodrugs GmbH. Prior to leon he was the Executive Chairman of Cedarburg Pharmaceuticals until the company was sold to Albany Molecular Research Inc. in 2014. From 2011 Ted was the Executive Chairman and CEO of Planet Biopharmaceuticals until the company was sold to Ares Life Sciences in 2014. From 2008 until 2011, he was President and CEO of CyDex Pharmaceuticals, Inc. at which time the company was sold to Ligand Pharmaceuticals, Inc. Prior to CyDex, Dr. Odlaug served as Managing Partner of EIR Healthcare Advisors, LLC. Prior to that, he was Executive Vice President and a member of the senior management committee at Fujisawa Healthcare Inc. until its merger with Yamanouchi in 2005, which resulted in the formation of Astellas Pharma. He left Astellas in 2006 after successfully supporting the U.S. post-merger integration process. Earlier in his career he had senior positions at Bayer AG and Baxter International Inc.
Ted holds Bachelor's and Master's degrees from the University of Missouri at Kansas City and a Ph.D. in Public Health from the University of Minnesota.
Pieter J. de Visser
Chief Financial Officer and Director, Waverley Pharma Inc.
Mr. de Visser was the managing and founding partner of DeVisser Gray LLP, Chartered Professional Accountants, a Vancouver firm that has provided services to the mining community for 25 years. Mr. de Visser has been a member of a technical advisory committee to the BC Securities Commission. Mr. de Visser is a director of Camino Minerals Corporation (TSXV: COR) and was previously the Chief Financial Officer of Pretium Resources Inc. (TSX/NYSE: PVG). Mr. de Visser has also acted as Chief Financial Officer and Director of multiple TSXV-listed mining and life science companies. Mr. de Visser holds a Bachelor of Commerce degree from the University of British Columbia and is a Chartered Professional Accountant.